223 related articles for article (PubMed ID: 31839374)
1. Overcoming the Brain Barriers: From Immune Cells to Nanoparticles.
Charabati M; Rabanel JM; Ramassamy C; Prat A
Trends Pharmacol Sci; 2020 Jan; 41(1):42-54. PubMed ID: 31839374
[TBL] [Abstract][Full Text] [Related]
2. Immune cells: potential carriers or agents for drug delivery to the central nervous system.
Zhang SS; Li RQ; Chen Z; Wang XY; Dumont AS; Fan X
Mil Med Res; 2024 Mar; 11(1):19. PubMed ID: 38549161
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system delivery of molecules across the blood-brain barrier.
Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
Nair KGS; Ramaiyan V; Sukumaran SK
Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
[TBL] [Abstract][Full Text] [Related]
5. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
Cramer S; Rempe R; Galla HJ
Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticles for drug delivery to the central nervous system.
Patel T; Zhou J; Piepmeier JM; Saltzman WM
Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
[TBL] [Abstract][Full Text] [Related]
8. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
9. The blood-central nervous system barriers actively control immune cell entry into the central nervous system.
Engelhardt B
Curr Pharm Des; 2008; 14(16):1555-65. PubMed ID: 18673197
[TBL] [Abstract][Full Text] [Related]
10. Strategies for drug delivery to the central nervous system by systemic route.
Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicines for the Treatment of CNS Diseases.
Reynolds JL; Mahato RI
J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
[TBL] [Abstract][Full Text] [Related]
12. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable polymeric nanoparticles administered in the cerebrospinal fluid: Brain biodistribution, preferential internalization in microglia and implications for cell-selective drug release.
Peviani M; Capasso Palmiero U; Cecere F; Milazzo R; Moscatelli D; Biffi A
Biomaterials; 2019 Jul; 209():25-40. PubMed ID: 31026609
[TBL] [Abstract][Full Text] [Related]
14. Crossing the blood-brain barrier with nanoparticles.
Zhou Y; Peng Z; Seven ES; Leblanc RM
J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
16. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
17. From the Blood to the Central Nervous System: A Nanoparticle's Journey Through the Blood-Brain Barrier by Transcytosis.
Fullstone G; Nyberg S; Tian X; Battaglia G
Int Rev Neurobiol; 2016; 130():41-72. PubMed ID: 27678174
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
[TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
20. Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS.
Grossi C; Guccione C; Isacchi B; Bergonzi MC; Luccarini I; Casamenti F; Bilia AR
Planta Med; 2017 Mar; 83(5):382-391. PubMed ID: 27002395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
